急性胰腺炎治療的研究進(jìn)展

11 Barnett CC,Moore EE, Moore FA, et al.Soluble intercellul �瞐radhesionmolecule��1 provokes polymorphonuclear leukocytee lastase release by CD18.Surg,2006,120:395��401. 　　

12 Malfertheiner P,Dominguez�睲unoz JE.Prognostic factors in acute pancreatitis.Int J Pancreatol,2003,14:1��8. 　　

13 Doherty NS, Dinerstein RJ, Mehdi S.Novel inhibitors of polymorphonuclear neutrophil (PMN) elastase and cathepsin G: evaluation in vitro of their potiential for the treatment of inflammatory connective tissue damage. Int J Immunop�瞙armacol,2000,12:787��795. 　　

14 Essani NA,Fisher MA,Farhood A,et al.Cytokine�瞚nduced upregulation of hepatic intercellular adhesion molecule��1 messenger RNA expression and its role in the pathophysiology of murine endotoxin shock and acute liver�瞗alure.Hepatology,1995,21:1632��1639. 　　

15 Diamond MS, Staunton DE,Marlin SD,et al.Binding of the integrin Mac��1(CD11b/CD18) and its regulation by glycosyation.Cell, 2001,65:961��971. 　　

16 李清懷,張彥榮，高原,等.重癥急性胰腺炎時(shí)胰腺細(xì)胞間黏附分子��1在胰腺組織的表達(dá)及其單克隆抗體的阻斷效果. 中國(guó)實(shí)用外科雜志,2004,24：248. 　　

17 馮新富,盧靈軍,陳曉理，等.5�睩u對(duì)大鼠急性胰腺炎炎癥相關(guān)細(xì)胞因子的調(diào)節(jié)作用.中國(guó)普通外科雜志,2003，12：747��750. 　　

18 董瑞,王自法,呂毅，等.大劑量地塞米松治療重癥急性胰腺炎的實(shí)驗(yàn)研究.中國(guó)普通外科雜志,2001,10：309��312. 　　

19 吳浩,陳曉理,黃興蘭，等.生長(zhǎng)抑素對(duì)大鼠急性胰腺炎免疫調(diào)節(jié)作用.中華急診醫(yī)學(xué)雜志,2003,12：103��105. 　　

20 陳紫千,湯耀卿,張軼，等.白介素��10基因治療重癥急性胰腺炎的實(shí)驗(yàn)研究.外科理論與實(shí)踐，2004,9：185��188. 　　

21 Satoch A, Shimosegawa T, Fujita M, et al, Inhibition of nuclear factor�瞜appa B activation improves the survival of rats with taurocholate pancreatitis.Gut,1999，44:253��258. 　　

22 Kaiser AM, Saluja AK,Lu L,et al.Effects of cycloheximide on pancreayiyis.endonuclease activity,apoptosis,and severity ofacute pancreatitis.Am J Physiol,2006,271:C982�睠993.       

23 趙雪峰，張志棟，李勇，等.急性重癥胰腺炎的外科治療.河北醫(yī)藥，2008，30：1126��1127.

上一頁  [1] [2] [3] [4] [5] [6]  下一頁